U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432659) titled 'Add-On ZIDA Sock Therapy for Overactive Bladder' on Feb. 10.
Brief Summary: Many people with overactive bladder (OAB) continue to experience symptoms despite pharmacologic treatment. This study evaluates the use of the ZIDA Control Sock, an FDA-cleared, noninvasive wearable device that delivers mild electrical stimulation near the ankle, as an adjunct to usual care. Adults with OAB-wet who remain symptomatic on stable medication will use the device at home once weekly for 12 weeks while continuing their prescribed therapy. The study collects clinical, patient-reported, and safety information during adjunctive device use.
Study Star...